OM Tx
1 known investors
Om (OMTX) builds proteome-wide protein-ligand interaction models, LULA-1 and LULA-2, that predict how strongly molecules bind a target from just a protein sequence and SMILES string, along with large-scale wet-lab data generation and molecule fulfillment for drug discovery programs. It serves pharmaceutical and biotech researchers, offering hosted scoring, an API/SDK, and MCP integrations to run discovery workflows.